-
TACI Polymorphisms Associated with Allograft Rejection in Mice and in Man
-
TACI-Ig as a Desensitization Agent in a Rat Model of Antibody Mediated Rejection
-
Tacrolimus and Isavuconazole Therapy: What about the Drug Interaction?
-
Tacrolimus Exposure in Human Proximal Tubule Cells Results in Differentially Increased CTGF Expression in Relation to Pharmacogenetic Variants of CYP3A5 and ABCB1
-
Tacrolimus Metabolism in Subjects with Potentially Absent CYP3A Activity
-
Tacrolimus Pharmacokinetics (PK) at Low, Medium, and High Trough Levels in Patients Converted from Twice-Daily Immediate-Release Tacrolimus (TacBID) to Once-Daily Extended-Release Tacrolimus (LCPT)
-
Tacrolimus-Based Maintenance Immunosuppression Decreases the Number of Peripheral Blood Transitional B Cells in Nonhuman Primates
-
Taking Specific Steps to Pursue Living Donor Kidney Transplant is Associated with Greater Odds of Having a Potential Living Donor Identified
-
Taking Your Center's Temperature: Using a Heat Map to Target Your Transplant-Specific Education for Regulatory Compliance
-
Target Tacrolimus Troughs and CYP3A5 Polymorphisms Do Not Predict Therapeutic Drug Exposure in African American and Caucasian Renal Transplant Recipients
- « Previous Page
- 1
- …
- 177
- 178
- 179
- 180
- 181
- …
- 211
- Next Page »